BSX Q2 2017 Earnings — Boston Scientific Corporation Revenue & Financial Results | Market Cap Arena

BSXBoston Scientific Corporation

$103B

Q2 2017 Earnings

Healthcare Medical - Devices

Income Statement

Revenue

$2.3B+6.2% YoY

Gross Profit

$1.5B65.0% margin

Operating Income

$395M17.5% margin

Net Income

$146M6.5% margin

EPS (Diluted)

$0.10

QoQ Revenue Growth

+4.5%

Cash Flow

Operating Cash Flow

$297M

Free Cash Flow

$210M

Stock-Based Comp.

$32M

Balance Sheet

Total Assets

$18.4B

Total Liabilities

$11.1B

Stockholders' Equity

$7.2B

Cash & Equivalents

$195M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$2.3B	$2.1B	+6.2%
Gross Profit	$1.5B	$1.5B	+0.1%
Operating Income	$395M	-$334M	+218.3%
Net Income	$146M	-$207M	+170.5%

Revenue Segments

Cardiovascular

$889M51%

MedSurg

$841M49%